Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Domesco Medical Import Export JSC (STC:DMC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Domesco Medical Import Export JSC's Enterprise Value for the quarter that ended in Jun. 2026 was ₫1,463,749 Mil.
Domesco Medical Import Export JSC's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫287,797 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Domesco Medical Import Export JSC EV-to-EBIT Related Terms
Domesco Medical Import Export JSC EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Domesco Medical Import Export JSC EV-to-EBIT Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Domesco Medical Import Export JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Domesco Medical Import Export JSC EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Domesco Medical Import Export JSC's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Domesco Medical Import Export JSC's EV-to-EBIT falls into.
Domesco Medical Import Export JSC's current Enterprise Value is ₫1,633,667 Mil.
Domesco Medical Import Export JSC's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫287,797 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Domesco Medical Import Export JSC (STC:DMC) has a EV-to-EBIT of 5.68 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Domesco Medical Import Export JSC and its competitors. This is 28% below median its historical median of 7.89. Over the past decade, Domesco Medical Import Export JSC's EV-to-EBIT has ranged from 4.05 to 21.59. According to the industry distribution chart, Domesco Medical Import Export JSC ranks #108 out of 690 companies in the Drug Manufacturers industry, placing it in the top 15.7%.
Is Domesco Medical Import Export JSC's EV-to-EBIT too high?
Domesco Medical Import Export JSC's current EV-to-EBIT of 5.68 is 28% below median its 10-year median of 7.89. Over the past 10 years, this metric has ranged from a low of 4.05 to a high of 21.59. The Drug Manufacturers industry median EV-to-EBIT is 15.46. Domesco Medical Import Export JSC's value of 5.68 is 63.3% below this industry median. Based on the distribution chart, Domesco Medical Import Export JSC ranks #108 out of 690 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Domesco Medical Import Export JSC has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Domesco Medical Import Export JSC's EV-to-EBIT compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Domesco Medical Import Export JSC ranks #108 out of 690 companies for EV-to-EBIT. This places Domesco Medical Import Export JSC in the top 16% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.46. Domesco Medical Import Export JSC's value of 5.68 is 63.3% below this benchmark. Historically, Domesco Medical Import Export JSC's own EV-to-EBIT has ranged from 4.05 to 21.59 over the past decade. While the company's 10-year median is 7.89 vs. the industry median of 15.46, Domesco Medical Import Export JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.46, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Domesco Medical Import Export JSC's current EV-to-EBIT of 5.68 is 63.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Domesco Medical Import Export JSC and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Domesco Medical Import Export JSC's current EV-to-EBIT is 5.68, which is 28% below median its own 10-year median of 7.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Domesco Medical Import Export JSC stock overvalued right now?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC (STC:DMC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫68,156.91, compared to a current price of ₫57,800.00 — trading 15.2% below its estimated fair value. The current EV-to-EBIT is 5.68, which is 28% below median its 10-year median of 7.89 and 63.3% below the Drug Manufacturers industry median of 15.46. Domesco Medical Import Export JSC's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Domesco Medical Import Export JSC (STC:DMC), the current EV-to-EBIT is 5.68 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Domesco Medical Import Export JSC (STC:DMC) Overvalued in 2026?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC stock appears to be undervalued.
The current stock price of ₫57,800.00 is trading 15.2% below its estimated GF Value™ of ₫68,156.91.
GuruFocus considers Domesco Medical Import Export JSC to be Modestly Undervalued.
Key valuation signals for STC:DMC:
EV-to-EBIT: 5.68 (28% below median its 10-year median of 7.89)
GF Value™: ₫68,156.91 vs. price of ₫57,800.00 (15.2% below fair value)
Industry Position: 63.3% below the Drug Manufacturers median (#108 of 690)
No single metric tells the full story. See the STC:DMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Domesco Medical Import Export JSC Business Description
Domesco Medical Import Export JSC is specialized in research, development, production, marketing and trading of Pharmaceuticals, medicines derived from Pharmaceutical materials, functional food, pure drinking water and medical beverages. It operates in import and export of medicines, medicine materials, food - functional foods, medical supplies, and medical equipment for medical examination and treatment for the whole people.
76GF Score
Get the complete analysis for STC:DMC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DMC has been successfully added to your 
